Compound ID | 156
Class: Antibiofilm agent
| Spectrum of activity: | Gram-positive |
| Details of activity: | MRSA (methicillin resistant Staphylococcus aureus), Staphylococcus epidermidis, Pseudomonas aeruginosa, and Candida albicans biofilms |
| Combined with other compounds: | Yes |
| Institute where first reported: | Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA |
| Year first mentioned: | 2013 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/4510 |
| Citations: |
|
| Patent: | US9913820B2 |